Filing Details
- Accession Number:
- 0001578563-25-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-14 18:59:50
- Reporting Period:
- 2025-01-13
- Accepted Time:
- 2025-01-14 18:59:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1665988 | Bioventus Inc. | BVS | Surgical & Medical Instruments & Apparatus (3841) | 810980861 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2005474 | E Robert Claypoole | 4721 Emperor Boulevard, Suite 100 Durham NC 27703 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2025-01-13 | 28,786 | $9.10 | 64,964 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Reflects shares sold to cover taxes upon the vesting of restricted stock units on January 10, 2025 pursuant to a standing 10b5-1 instruction adopted on January 11, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.935 to $9.22, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.